Denosumab is a RESTRICTED formulary medication. Denosumab use is restricted to Hem/Onc prescribers and will only be stocked pursuant to an active patient whose insurance requires buy and bill. White bag is the primary insurance preference for this medication.
Preferred biosimilar agent for Inpatient use: Bomyntra (-bnht)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).
Add Formweb to your mobile device
Denosumab is a RESTRICTED formulary medication. Denosumab use is restricted to Hem/Onc prescribers and will only be stocked pursuant to an active patient whose insurance requires buy and bill. White bag is the primary insurance preference for this medication.
Preferred biosimilar agent for Inpatient use: Bomyntra (-bnht)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).